Metraipolis › archive › dc_d86c3effc55e

Zilebesiran as an Innovative siRNA-Based Therapeutic Approach for Hypertension: Emerging Perspectives in Cardiovascular Medicine — Europe PMC PMID:41226756

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41226756
DOI
10.3390/ijms262110717
License (as archived)
solo-consultazione
Archived
2026-11-08T19:25:48.724Z
SHA-256 of the archived text
b535859c323fa99d43b703b92e5a741ca74902a182cfbce52af76e43a8543025
Stable URL of this page
https://metraipolis.com/documento/dc_d86c3effc55e

How to cite

Zilebesiran as an Innovative siRNA-Based Therapeutic Approach for Hypertension: Emerging Perspectives in Cardiovascular Medicine — Europe PMC PMID:41226756 — Europe PMC (en), https://europepmc.org/article/MED/41226756 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d86c3effc55e (Metraipolis archive dc_d86c3effc55e, sha256 b535859c323fa99d43b703b92e5a741ca74902a182cfbce52af76e43a8543025)
BibTeX
@misc{dcd86c3effc55e,
  title = {Zilebesiran as an Innovative siRNA-Based Therapeutic Approach for Hypertension: Emerging Perspectives in Cardiovascular Medicine — Europe PMC PMID:41226756},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41226756},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d86c3effc55e; sha256 b535859c323fa99d43b703b92e5a741ca74902a182cfbce52af76e43a8543025},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41226756. Agents can read the archived copy with the MCP tool read_document.